Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1988-10-21
1990-07-03
Schwartz, Richard A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514319, 514323, 514324, 514397, 540603, 546196, 546200, 546202, 548336, A61K 3155, C07D40908
Patent
active
049391445
ABSTRACT:
The invention relates to ketones of the general formula (I): ##STR1## wherein Im represents an imidazolyl group of the formula: ##STR2## one of the groups represented by R.sup.1, R.sup.2 and R.sup.3 is a hydrogen atom or a C.sub.1-6 alkyl, C.sub.3-7 cycloalkyl, C.sub.3-6 alkenyl, phenyl or phenyl C.sub.1-3 alkyl group, and each of the other two groups, which may be the same or different, represents a hydrogen atom or a C.sub.1-6 alkyl group;
REFERENCES:
patent: 4808581 (1989-02-01), Oxford et al.
patent: 4814344 (1989-03-01), Humber et al.
patent: 4822881 (1989-04-01), Coates et al.
patent: 4859662 (1989-08-01), Coates et al.
Bell James A.
Coates Ian H.
Ewan George B.
Humber David C.
Mitchell William L.
Glaxo Group Limited
Schwartz Richard A.
LandOfFree
Tricyclic ketone derivatives as 5-HT antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tricyclic ketone derivatives as 5-HT antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic ketone derivatives as 5-HT antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1890997